Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 54 announcements

Share price: ₹1,781.00
Market cap: ₹4,27,322 Cr
Revenue (annual): ₹58,462 Cr
Net profit (annual): ₹11,479 Cr
P/E (TTM): 35.3×Sector 47.3×
Promoter holding: 54.48%+0.00% QoQ
FII holding: 14.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12 May 2026 17:24 IST NSE

Sun Pharmaceutical Industries Management Change

Sun Pharmaceutical appointed Dr. Andreas Eugen Busch as an Independent Director for five years. His extensive global R&D expertise will strengthen the board's drug discovery leadership.

Execution: 60 months

Read the filing ↗

12 May 2026 17:20 IST BSE

Management Change

Sun Pharmaceutical Industries Management Change

Sun Pharmaceutical appointed Dr. Andreas Busch as Independent Director for five years. Ms. Rama Bijapurkar retires, and Ms. Satyavati Berera joins key committees.

Execution: 5 consecutive years

Read the filing ↗